Effectiveness of an oral cholera vaccine in Zanzibar: Findings from a mass vaccination campaign and observational cohort study

The Lancet Infectious Diseases

Volumn 12, Issue 11, 2012, Pages 837-844

  Khatib, Ahmed M ^a   Ali, Mohammad ^b   von Seidlein, Lorenz ^c   Kim, Deok Ryun ^b   Hashim, Ramadhan ^b   Reyburn, Rita ^b   Ley, Benedikt ^b   Thriemer, Kamala ^b   Enwere, Godwin ^d   Hutubessy, Raymond ^d   Aguado, Maria Teresa ^d   Kieny, Marie Paule ^d   Lopez, Anna Lena ^b   Wierzba, Thomas F ^b   Ali, Said Mohammed ^e   Saleh, Abdul A ^a   Mukhopadhyay, Asish K ^f   Clemens, John ^b   Jiddawi, Mohamed Saleh ^a   Deen, Jacqueline ^b,c  

^a Elderly and Children   (Tanzania)

^b International Vaccine Institute   (South Korea)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e Public Health Laboratory   (Tanzania)

^f NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; INACTIVATED VACCINE;

ADULT; ARTICLE; CHOLERA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FEMALE; GEOGRAPHY; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RESIDENT; RISK; RURAL AREA; TANZANIA; URBAN AREA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; COHORT STUDIES; FEMALE; HUMANS; IMMUNITY, HERD; INCIDENCE; MALE; MASS VACCINATION; MIDDLE AGED; TANZANIA; TREATMENT OUTCOME; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84867919591     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70196-2     Document Type: Article

References (27)

1. WHO Global Task Force on Cholera Control. Cholera vaccines: a new public health tool? Report of a WHO meeting, 10-11 December, 2002 (WHO/CDS/CPE/ZFK/2004.5).
2. Ali M, Deen J, Khatib A, et al. Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, East Africa. Bull World Health Organ 2010, 88:556-559.
3. Ali M, Rasool S, Park JK, et al. Use of satellite imagery in the construction of a household GIS database for health studies in Karachi, Pakistan. Int J Health Geogr 2004, 3:20.
4. Holmgren J, Berquist C Oral B subunit killed whole-cell cholera vaccine. New generation vaccines 2004, 499-510. Marcel Dekker, New York. 3rd edn. M.M. Levine, J.B. Kaper, R. Rappuoli, M.A. Liu, M.F. Good (Eds.).
5. Jertborn M, Svennerholm AM, Holmgren J Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 1993, 11:1007-1012.
6. Clemens JD, Stanton BF, Chakraborty J, et al. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J Infect Dis 1987, 155:79-85.
7. Ali M, Park JK, Thiem VD, Canh DG, Emch M, Clemens JD Neighborhood size and local geographic variation of health and social determinants. Int J Health Geogr 2005, 4:12.
8. The treatment of diarrhea: a manual for physicians and other senior health workers, 4th revision 2005, WHO, World Health Organization, Geneva.
9. WHO. Laboratory methods for the diagnosis of epidemic dysentery and cholera. Geneva (WHO/CDS/CSR/EDC/99/8/EN) 1999.
10. Lucas ME, Deen JL, von Seidlein L, et al. Effectiveness of a mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005, 352:757-767.
11. Ali M, Emch M, von Seidlein L, et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005, 366:44-49.
12. McPherson M, Smith-Lovin L, Cook J Birds of a feather: homophily in social networks. Annu Rev Sociol 2001, 27:415-444.
13. Morris M Network epidemiology: a handbook for survey design and data collection 2005, Oxford University Press, Oxford.
14. Meyers L, Newman M, Martin M, Schrag S Applying network theory to epidemics: control measures for Mycoplasma pneumoniae outbreaks. Emerg Infect Dis 2003, 9:204-210.
15. Meyers L Contact network epidemiology: bond percolation applied to infectious disease prediction and control. Bull Amer Math Soc 2007, 44:63-86.
16. Peltola H, Siitonen A, Kyrönseppä H, et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 1991, 338:1285-1289.
17. Clemens JD, Sack DA, Harris JR, et al. Cross protection by B subunit whole cell cholera vaccine against diarrhea associated with heat-labile toxin producing enterotoxigenic Escherichia coli: results of a large scale field trial. J Infect Dis 1988, 158:372-377.
18. Zeger SL, Liang KY, Albert PS Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44:1049-1060.
19. Oliver MA, Webster R Kriging: a method of interpolation for geographical information systems. Int J Geogr Inf Syst 1990, 4:313-332.
20. Agresti A Categorical data analysis 2002, 181-182. John Wiley & Sons, Hoboken, NJ.
21. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986, 2:124-127.
22. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM Oral vaccines for preventing cholera. Cochrane Database Syst Rev 2011, (3). CD008603.
23. Dorlencourt F, Legros D, Paquet C, Neira M, Ivanoff B, Le Saout E Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda. Bull World Health Organ 1999, 77:949-950.
24. Longini I, Nizam A, Ali M, Yunus M, Shenvi N, Clemens J Controlling endemic cholera with oral vaccines. PLoS Med 2007, 4:e336.
25. Scott DW Multivariate density estimation: theory, practice, and visualization 1992, J Wiley, New York.
26. Diez Roux AV The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev 2004, 26:104-111.
27. Glass RI, Becker S, Huq MI, et al. Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol 1982, 116:959-970.